Danaher Corporation (DHR) Competitors & Peers
The 5 largest companies in the same industry as Danaher Corporation, by market value — each comparable links to its own dossier. Numbers are code-computed, never estimated.
| Ticker | Relationship | Price | Comparables |
|---|---|---|---|
| TMO | Competitor | $719.42 | P/E 37.9RSI 60Cap 267.4 B |
| IDXX | Peer | $696.64 | P/E 46.9RSI 71Cap 55.0 B |
| NTRA | Peer | $311.98 | RSI 31Cap 44.7 B |
| A | Competitor | $178.01 | P/E 35.1RSI 56Cap 50.3 B |
| IQV | Peer | $275.23 | P/E 33.5RSI 56Cap 45.9 B |
How these relationships were derived
Every relationship below carries its provenance. A confirmed edge is sourced from a public filing or disclosure and links to it; an AI-inferred edge is surfaced by the relationship model and is unverified — shown for color, not as evidence.
Confirmed relationships (cited)
Sourced from a public filing or disclosure — each links to its origin.
- RGENSupplier
Own 10-Q customer-concentration disclosure: Cytiva = 12% of revenue.
Confirmed — SEC filing / public disclosuresec.gov ↗
Model-inferred relationships (unverified)
Suggested by the relationship model, with no public source on file. Treat each as a lead worth checking, not as evidence.
- TMOCompetitor
Top life-sci tools competition.
Model-inferred, unverified — treat as a lead, not evidence - ACompetitor
Lab instruments overlap.
Model-inferred, unverified — treat as a lead, not evidence - BIOCompetitor
Diagnostics + life-sci overlap.
Model-inferred, unverified — treat as a lead, not evidence - LLYSupplier
Danaher's life sciences segment provides essential bioprocessing equipment and filtration tech used in peptide synthesis.
Model-inferred, unverified — treat as a lead, not evidence